EKV-14550-77045 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2022-01-28
Dose 1 — Pfizer-BioNTech
2022-01-29
Registered in v-safe
2022-01-29
Survey response — days 1–6 daily, dose 1, dependent
MedDRA: Dizziness, Pyrexia, Somnolence, Unevaluable event — Feeling: Poor · Fever · Chills, Headache, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional

Free text: Systemic reaction (other): Fever, dizziness, sleepy · Healthcare visit (other): None

MedDRA releases: 2024-11 · check-in free text available
2022-01-29
Report sent to call center — days 1–6 daily, dose 1, dependent
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

1 call case(s)
2022-01-30
Health check-in — days 1–6 daily, dose 1, dependent
Feeling: Good · None

Adult check-in
2022-02-02
Survey response — days 1–6 daily, dose 1, dependent
MedDRA: Dizziness — Feeling: Fair · Site: Redness · Fatigue or tiredness

Free text: Dizziness

MedDRA releases: 2024-11 · check-in free text available
2022-02-06
Survey response — day 7, dose 1, dependent
MedDRA: Dizziness — Feeling: Good

Free text: Occassional dizziness

MedDRA releases: 2024-11 · check-in free text available
2022-02-11
Survey response — day 14, dose 1, dependent
MedDRA: Headache — Feeling: Fair

Free text: Mild headache

MedDRA releases: 2024-11 · check-in free text available
2022-02-11
Call 1 — Left Voicemail
2022-02-14
Call successful
Participant prefers to complete VAERS report online
2022-02-18
Dose 2 — Pfizer-BioNTech
2022-03-06
Survey response — day 14, dose 2, dependent
MedDRA: Dizziness — Feeling: Good

Free text: Dizziness

MedDRA releases: 2024-11 · check-in free text available
2022-03-18
Health check-in — day 28, dose 2, dependent
Feeling: Good

Adult check-in
2022-03-27
Survey response — day 35, dose 2, dependent
MedDRA: Cough, Nasopharyngitis — Feeling: Fair

Free text: Some colds, and occassional cough

MedDRA releases: 2024-11 · check-in free text available
2022-05-20
Health check-in — 3 months, dose 2, dependent
Feeling: Good

Adult check-in
2022-08-21
Health check-in — 6 months, dose 2, dependent
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2022-01-28	Pfizer-BioNTech	No
2	2022-02-18	Pfizer-BioNTech	No

Call center

1 call center case

1 successful

See the call center timeline

Free text

Release 11 — days 1–6 daily, dose 1, dependent

2022-01-29

Systemic reaction (other): Fever, dizziness, sleepy

Healthcare visit (other): None

2022-02-02

Systemic reaction (other): Dizziness

Release 11 — day 7, dose 1, dependent

2022-02-06

Systemic reaction (other): Occassional dizziness

Release 11 — day 14, dose 1, dependent

2022-02-11

Symptoms: Mild headache

Release 11 — day 14, dose 2, dependent

2022-03-06

Symptoms: Dizziness

Release 11 — day 35, dose 2, dependent

2022-03-27

Symptoms: Some colds, and occassional cough

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Unevaluable event	·	·	✓
SD	Cough	·	·	✓
SD	Dizziness	·	·	✓
SD	Headache	·	·	✓
SD	Nasopharyngitis	·	·	✓
SRO	Dizziness	·	·	✓
SRO	Pyrexia	·	·	✓
SRO	Somnolence	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release